WINTER NEWSLETTER

Welcome Page | Services | Office Hours and Directions | Newsletter Index
Meet the Medical Team | Recommended Links

Winter 2006

Newsletter Contents:
A Message from the Administrator
New Nerve Conduction Testing Available

A MESSAGE FROM THE ADMINISTRATOR

Would you like to receive Weaverville Family Medicine's quarterly newsletter directly to your email? If yes, then please click here and email your address to our website manager. If you have any questions for our office manager, you may reach Tom Crook at 645-3066.

NEW NERVE CONDUCTION TESTING AVAILABLE AT WEAVERVILLE FAMILY MEDICINE

Nerve conduction studies are used to assess damage to nerves such as from Carpal Tunnel Syndrome and Diabetic Peripheral Neuropathy. Neurodiagnostic testing is also useful in the evaluation of back pain or sciatica.

With the new Neurometrix test, now available at Weaverville Family Medicine, your doctor will have accurate and reliable results available quickly to help confirm the clinical assessment and expedite appropriate care.

Talk to your doctor if you are suffering from numbness or tingling in your arms or legs. You should also talk to your doctor if you think you might have nerve damage from diabetes. The Neurometrix test is completed in approximately 20 minutes. Leads will be attached with sticky pads to the area being tested. It is a virtually painless test done without needles. Some patients have described the test as no worse than being snapped with a rubber band. After your test is completed, your doctor will discuss your results with you, and possible treatment options for your symptoms. You may also be referred to a neurologist for further diagnostics or treatments.

Please join us this spring, for the next edition of the Weaverville Family Medicine Newsletter.
Do you have questions about The Weaverville Family Medicine Newsletter? For medical questions, please contact us at 645-3066. If you have a website related question or comment, then please contact our website manager.

return to top of page
return to Newsletter Index
return to Welcome Page